ArticleScientific reports2026
A clinical machine learning model for 1-year functional outcome prediction in acute ischemic stroke: temporal validation across evolving guidelines.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Accurate prediction of 1-year excellent functional outcome (modified Rankin Scale [mRS] 0–1) in acute ischemic stroke (AIS) patients is vital for guiding long-term rehabilitation. However, existing tools primarily focus on short-term (3-month) outcomes and often lack validation in temporally distinct cohorts, particularly when clinical guidelines and treatment landscapes evolve. To address this, we trained six machine learning models on a derivation cohort (n = 965, admitted 2020–2023) managed under the 2018 Chinese Guidelines for Diagnosis and Treatment of Acute Ischemic Stroke. The optimal logistic regression (LR) model included eight key predictors: admission NIHSS, admission mRS, age, neutrophil‑to‑lymphocyte ratio (NLR), glucose, blood urea nitrogen (BUN), D‑dimer, and B-type natriuretic peptide (BNP). The LR model was rigorously assessed on an independent temporal validation cohort (n = 144, admitted 2024) treated under the 2023 Guidelines, which expanded indications for reperfusion therapy. Although the validation cohort showed significantly higher thrombolysis rates and milder symptoms than the derivation cohort, the LR model demonstrated robust performance (AUC = 0.80, 95% CI: 0.72–0.87), significantly outperforming admission National Institutes of Health Stroke Scale (NIHSS) score (AUC = 0.73, 95% CI: 0.64–0.81). The model also showed substantial incremental value with a net reclassification improvement of 0.71 and an integrated discrimination improvement of 0.14 (both P < 0.001). Finally, an open‑access web‑based predictor was deployed to facilitate clinical implementation within the first 24 h of admission. In summary, we developed and temporally validated a robust, interpretable prediction model for 1-year functional outcome in AIS, offering a practical tool for long-term prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.